In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IRhythm Technologies brings in $6.7mm through its Series C venture round; adds $7mm

Executive Summary

One year after completing its $10mm Series B financing, iRhythm Technologies Inc. (diagnostic monitoring devices) has raised $6.7mm through its Series C venture round. According to the Form D, an additional $8.3mm is expected. New investor New Leaf Venture Partners led (and contributes a board member) and was joined by current backers Mohr Davidow Ventures, Synergy Life Science Partners, St. Jude Medical, and other three other undisclosed shareholders. The company will use the proceeds to market its Zio patch, an ambulatory cardiac rhythm monitor that can be used for up to two weeks.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies